{"product_id":"igf2bp1-imp1-antibody-sc-f4017","title":"IGF2BP1\/IMP1 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eIGF2BP1\/IMP1 is a target of interest in many antibody-based workflows. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1), also called IMP1, is an evolutionarily conserved RNA-binding protein involved in post-transcriptional gene regulation through modulation of mRNA stability, localization, and translation. IGF2BP1 contains multiple RNA recognition motifs (RRMs) and K homology (KH) domains, which mediate its selective binding to target mRNAs, often within their 3' untranslated regions, thereby affecting their fate in the cell. Depending on the literature source, IGF2BP1\/IMP1 may also be discussed as IGF2BP1\/IMP1 and CRDBP.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell projection, cytoplasm, nucleus, and synapse, which can matter when signal is compared across treatments or changing cell states. Following IGF2BP1\/IMP1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eIGF2BP1\/IMP1 is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell projection, cytoplasm, and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cell projection, cytoplasm, and nucleus across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003cli\u003etime-matched comparisons so changes reflect biology rather than handling or sampling drift\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for IGF2BP1\/IMP1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in IGF2BP1\/IMP1 reflect biology rather than handling. When interpreting IGF2BP1\/IMP1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep IGF2BP1\/IMP1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57578054746457,"sku":"F4017-20UL","price":149.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57578054779225,"sku":"F4017-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57578054811993,"sku":"F4017-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F4017-IF.png?v=1773601601","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/igf2bp1-imp1-antibody-sc-f4017","provider":"Absource Diagnostics","version":"1.0","type":"link"}